Modification of sucrose accumulation

Abstract: A sequence from the gene encoding SPS is used, in sense or antisense orientation to transform potato such that less sugar is stored in the tubers of the transformed plant.

Description: The subject invention relates to a process of reducing the accumulation of sugar in the tubers of potato plants. It is an object of the invention to effect a reduction in the amount of sucrose and/or free sugars derived from sucrose in potato tubers and/or one or more of sucrose, glucose or fructose formed from starch in potato tubers. It has been suggested that sucrose phosphate synthase (SPS) (EC2.3.1.14) regulates the synthesis of sucrose in the leaves of higher plants (Stitt, M., Quick, P., Physiologia Plantarum 77 633-641, 1989) and that the enzyme occurs in tissues which synthesise sucrose (Stitt, M., Huber, S., and Kerr, P., The Biochemistry of Plants 10 327-409, 1987, Academic Press). Sucrose accumulates in potato tubers stored at low temperatures. Such accumulation of sugars at low temperature presents a significant problem to processors of potatoes. For example, producers of crips and chips (french fries) have found that the presence of increased sugar tends to cause undue browning of the products during the frying process. The subject invention provides a process for the preparation of a transgenic plant, which process comprises transforming a potato cell with a chimaeric gene comprising a suitable promoter for expression in a cell of a potato tuber and SEQ ID No. 1 (as herein defined) in sense or antisense orientation and regenerating a potato plant from the transformed cell, whereby in respect of the regenerated plant, as compared to a control plant not the product of said process, less of the sucrose imported into the tuber(s) from non-tuber parts of the plant is stored as sucrose and/or free reducing sugar in the tuber(s) and/or less of one or more of sucrose, glucose or fructose is formed from starch stored in the tuber(s). The promoter should be such as to ensure that the sequence SEQ ID No. 1 is expressed in the nonphotosynthetic storage cells of the potato tuber. The genome from which the sense or antisense sequence is derived may be, for example, potato, but the sequence may be derived from any other organism comprising a sugar reduction sequence which is sufficiently homologous to the endogenous sequence in the target potato plant. It is a result of carrying out the invention that the synthesis of sugar is reduced. A procedure used to produce the chimaeric gene will now be illustrated by way of example. Purification of SPS from potato tubers. All procedures are performed at 4°C unless otherwise stated. Extraction: 10kg of potato tubers are washed thoroughly and any damaged or diseased tubers are discarded prior to further processing. Five 2kg batches of washed tubers are diced and juiced, using a Waring commercial juice extractor. The resultant juice is collected into 1000ml of 2 x extraction buffer (60mM HEPES pH7.5, 10mM MgCl 2 , 8mM DTT, 4mM EDTA, 10mM NaF, 2mM PMSF, 0.2 µM Pepstatin A and 20% glycerol (v:v) with 200g of insoluble PVP) . The collected juice and buffer are continually stirred to ensure complete mixing. Approximately 2.5l of extract was obtained from 2kg of potatoes. PEG precipitation: A 50% (w:v) PEG6000 solution is used to adjust the extract to a PEG concentration of 5% (1:9 v:v PEG to extract). After stirring for 15 min the extract is centrifuged at 9000g in a Beckman centrifuge, model J2-21, using a JA10 rotor for 20 min. The supernatant from each 2kg batch is retained and combined. Q-Sepharose anion column : The bulked supernatant from PEG precipitation (ca. 141 for 10kg of tubers) is diluted by a factor of two with water then batch absorbed onto 1500 g of Q-sepharose resin (Pharmacia) for 4-6h. The resin is then poured into a 10 x 200cm column. Subsequently the column is washed with 2l of 50 mM NaCl in equilibration buffer, followed by 500mM NaCl in equilibration buffer and then 750 mM NaCl in equilibration buffer (2l each). Finally the column is eluted with 4l of equilibration buffer containing 1M NaCl. Fractions are collected and assayed for SPS activity and protein content. Phenyl sepharose hydrophobic column : A 300ml column (Pharmacia XK-50) is filled with phenyl sepharose CL4B (Pharmacia) which has been treated with 11 of 6M urea, washed with 2l distilled water and equilibrated with 21 of buffer (MOPS 30mM pH7.0, MgCl 2 5mM, DTT 2mM, EDTA 0.5mM). The fractions from the Q-Sepharose column (ca. 1000ml) containing SPS activity are combined and loaded onto the column at 1ml/min. The column is then washed with the equilibration buffer until the optical density of the eluent at 280nm has returned to background. The SPS is then eluted from the column with equilibration buffer containing 6M urea. Fractions (15ml) are collected and assayed for SPS activity. SPS containing fractions are pooled, dialysed against column equilibration buffer concentrated against 50% PEG 6000 made up in the same buffer, reassayed for SPS activity and protein, and stored at -80°C after the addition of glycerol to 20% v:v. In this state SPS activity is partially stable for up to eight months providing that repeated freeze thaw cycles are avoided. Fructose-6-phosphate Sepharose (Fru-6-P) affinity column : 30ml of Sepharose bound Fru-6-P resin manufactured as described below is loaded into a Pharmacia XK26 column as a slurry. The column is then equilibrated with 20 column volumes of buffer (30mM MOPS-NaOH pH7.0, 5mM DTT, 10% glycerol, 5mM isoleucine). Peak SPS activity derived from the phenyl column containing up to 100mg of protein is loaded onto the column at 1ml/min. To elute SPS, the column is washed with ten column volumes of buffer (30mM MOPS-NaOH pH7.0, 5mM DTT, 10% glycerol, 5mM isoleucine), followed by ten column volumes of the same buffer modified by the addition of 400mM NaCl. Finally the column is eluted with ten volumes of base buffer plus 400mM NaCl and 100mM Fru-6-P. Fractions are taken throughout the elution and assayed for SPS activity and protein content. The peak activity region is identified and dialysed against buffer (30mM MOPS-NaOH pH7.0, 5mM DTT, 0.5mM EDTA, 10% glycerol). SPS activity from this stage, to the end of the purification becomes progressively less stable and very susceptible to freeze thaw stress; therefore it is important to omplete the purification rapidly and avoid freezing of the sample. Mono Q anion column : The dialysed SPS sample is passed through a 0.22µm filter and up to 30mg of protein loaded onto an HR 10/10 Mono Q column set up on an FPLC (Pharmacia). The column is prepared by washing with 50ml of 1M NaCl in buffer (30mM MOPS-NaOH pH7.0, 5mM DTT, 0.5mM EDTA, 10% glycerol), followed by 50ml of equilibration buffer. The column is then eluted until the optical density at 280nm returns to its baseline value. A 0-500mM NaCl gradient is then run over 50ml and 1ml fractions assayed for SPS activity, active fractions combined and reassayed for SPS and protein. The sample is then concentrated against 50% PEG6000 made up in equilibration buffer before dialysing against equilibration buffer. UDPG agarose affinity column : Up to 5mg of protein from the Mono Q SPS fraction is loaded onto a UDP glucuronic acid agarose column (5ml) that has been equilibrated with 25ml of base buffer (30mM MOPS- NaOH pH7.0, 5mM DTT, 0.5mM EDTA, 10% glycerol). After 15 min the loaded sample is displaced with buffer, collected and reloaded twice more for 15 min each time. The column is then washed with 25ml of equilibration buffer, followed by 20ml of equilibration buffer containing 50mM KC1 to remove weakly bound proteins. The major SPS fraction is then eluted with equilibration buffer containing 125mM KC1 followed by 50ml of buffer containing 250mM KC1. Fractions are collected and assayed for SPS activity and protein content. Cyanogen Bromide cleavage of peptides for internal sequence analysis 500µg of SPS enriched protein preparation from UDPG-agarose stage of the purification schedule is fractionated by an SDS-PAGE 7.5% Laemmli gel and the separated proteins are transblotted onto PVDF membrane. The membrane is then stained for 30 min with Ponceau S (0.5%) in 1% acetic acid. Following destaining in water the protein band of interest is excised from the membrane and cut into 2-3mm square fragments which are placed in an Eppendorf tube. 150µl of 0.5M CNBr in 70% formate (v:v) is added and the tube incubated in the dark at 25°C for 16h with occasional agitation. Excess reagent is removed by evaporation under vacuum. When dry 50µl of de-ionised water is added, the tube vortexed and the sample re-dried in the vacuum centrifuge. This is repeated a further three times. After removal of cleavage reagent, 70µl of elution buffer containing 2% SDS and 1% triton X-100 in 500mM tris-HCl, pH9.3, is added to the tube containing the sample. The sample is then incubated for 90min with careful agitation. Glycerol and Bromophenol blue to a final concentration of 6.25% and 0.001% respectively are then added. The dissolved peptide fragments are then fractionated according to size on a 15% Shagger acrylamide gel and transblotted onto PVDF membrane. The amino acid sequence of the peptides are then determined by Edman degradation (Eur. J. Biochem, 20 , 89-102, 1971). Production of transgenic plants with decreased sugar An oligonucleotide may be prepared to the amino acid sequence PEEITKE and used to probe a potato tuber cDNA library. A clone containing the DNA sequence (referred to as SEQ ID No. 1) was obtained and blunt end ligated into the plasmid pFW4101 in place of the GUS (β-glucuronidase) coding sequence to give plasmid pFW4131 when SEQ ID No. 1 is in the sense orientation or pFW4132 (drawing herewith) when the SEQ ID No. 1 is in the antisense orientation. pFW4101 is constructed with a patatin promoter made from two genomic clones PS3 and PS27. The patatin fragments PS3 and PS27 are derived from the genomic clones described by Mignery et al (Gene 62 , 27-44, 1988). The fragments consist of -3.5kb to -1kb of PS3 and -1kb to +3 of PS27 numbered in relation to the translation start. E. coli harbouring pFW4101 was previously deposited, under the Budapest Treaty on International Recognition of the Deposit of Micro-Organisms for the Purposes of Patent Procedure, at the National Collection of Industrial and Marine Bacteria, Aberdeen, GB on 5th July 1990 under accession number NCIMB40306. The vectors pFW4101 (control), pFW4131 (sense) and pFW4132 (antisense) were transferred separately into Agrobacterium tumefaciens strain LBA4404 by triparental mating. The Agrobacterium strains were used to transform the potato cultivar Desirée. Those transgenic plants that express the chimaeric gene sufficiently strongly will have a decreased amount of sucrose and/or total reducing sugars.

Claims: A process for the preparation of a transgenic plant, which process comprises transforming a potato cell with a chimaeric gene comprising a suitable promoter for expression in a cell of a potato tuber and SEQ ID No. 1 in sense or antisense orientation and regenerating a potato plant from the transformed cell, whereby in respect of the regenerated plant, as compared to a control plant not the product of said process, less of the sucrose imported into the tuber(s) from non-tuber parts of the plant is stored as sucrose and/or free reducing sugar in the tuber(s) and/or less of one or more of sucrose, glucose or fructose is formed from starch stored in the tuber(s). The nucleotide sequence SEQ ID No. 1.

Inventors: BLUNDY KEITH STUART, BURRELL MICHAEL MEYRICK, MORRIS GEORGE STEPHEN, THOMAS CHRISTOPHER JOHN ROBERT, BLUNDY, KEITH STUART, BURRELL, MICHAEL MEYRICK, MORRIS, GEORGE STEPHEN, THOMAS, CHRISTOPHER JOHN ROBERT
Applicants: CAMBRIDGE ADVANCED TECH, ADVANCED TECHNOLOGIES (CAMBRIDGE) LIMITED
Application year: 1992
Main classification: C12N15
IPC codes: C12N15, A01H5, C12N9